Similarly, the Kaplan–Meier analysis revealed that ALS patients with higher EOMES or CXCR3+EOMES expression in CD4+T‐cells developed more endpoint events (Figure 3). The gene discussed is CXCR3; the disease is amyotrophic lateral sclerosis.